Silkflex Polymer (SILKFLEX)

Score breakdown: P/E: 2/3 · ROCE: 1/2 · Growth: 2/2 · Dividend: 0/1

Key Financials

Strengths

• ROCE of 24.08% shows strong capital efficiency.
• Piotroski F-Score of 7/9 indicates solid underlying financial health.
• Promoter holding of 70.14% aligns owner and minority interests.
• Profit growth of 117.11% and PEG of 0.28 suggest attractive growth relative to valuation.
• Market cap of ₹162 Cr with P/E of 17.21 is not an excessive entry price.

Concerns

• Sales growth of just 5.37% is far behind profit growth, suggesting margin-driven profits that may not last.
• Zero dividend yield means returns depend entirely on future earnings and share price appreciation.
• Book value, ROE, and debt/equity are unavailable, limiting a proper Graham-style balance-sheet check.
• Small quarterly scale of ₹34 Cr sales and ₹4 Cr profit makes the business vulnerable to margin shocks.

AI Analysis

I am often wary of a business whose earnings jump far faster than its sales. Silkflex Polymer shows exactly that: profit up 117.11% while sales grew only 5.37%. That type of divergence can reflect a genuine margin turnaround, but it can also be a one-off. At ₹178, the market cap is ₹162 Cr and the P/E is 17.21, so I am not being asked to pay an absurd price. ROCE of 24.08% is genuinely attractive, and a Piotroski score of 7 out of 9 gives me some confidence that the financial health is not deteriorating. Promoters holding 70.14% is a positive; their interests are heavily tied to long-term value creation. The latest quarter, with ₹34 Cr sales and ₹4 Cr profit, implies a healthy net margin; if that can be sustained, the current valuation is reasonable. Yet I have no book value, ROE, or debt/equity figure, and Graham always demanded a balance sheet before granting trust. There is no dividend, so the only return is higher earnings or a higher multiple. The 52-week range of ₹76 to ₹228.75 also reminds me how volatile this small specialty chemical name can be. Still, a PEG of 0.28 suggests the market is not giving full credit to growth. I would classify it as a fast grower with an unproven moat, and I would only commit after several more quarters of improving revenue, not just profit. For now, it is on my watchlist — attractive, but not yet a certainty.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer